Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 12, 2012 - Issue 7
Submit an article Journal homepage
625
Views
14
CrossRef citations to date
0
Altmetric
Editorial

Tumor microenvironment regulates epithelial–mesenchymal transitions in metastasis

Dingcheng Gao Department of Cardiothoracic Surgery, Neuberger Berman Lung Cancer Research Center, Department of Cell and Developmental Biology, Weill Cornell Medical College of Cornell University, 1300 York Avenue, 525 East 68th Street, New York, NY 10065, USA. [email protected]
&
Vivek Mittal Department of Cardiothoracic Surgery, Neuberger Berman Lung Cancer Research Center, Department of Cell and Developmental Biology, Weill Cornell Medical College of Cornell University, 1300 York Avenue, 525 East 68th Street, New York, NY 10065, USA
Pages 857-859 | Published online: 10 Jan 2014

References

  • Kalluri R, Weinberg RA. The basics of epithelial–mesenchymal transition. J. Clin. Invest.119(6), 1420–1428 (2009).
  • Scheel C, Weinberg RA. Phenotypic plasticity and epithelial-mesenchymal transitions in cancer and normal stem cells? Int. J. Cancer129(10), 2310–2314 (2011).
  • Mani SA, Guo W, Liao MJ et al. The epithelial–mesenchymal transition generates cells with properties of stem cells. Cell133(4), 704–715 (2008).
  • Gal A, Sjöblom T, Fedorova L, Imreh S, Beug H, Moustakas A. Sustained TGF beta exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis. Oncogene27(9), 1218–1230 (2008).
  • Hennessy BT, Gonzalez-Angulo AM, Stemke-Hale K et al. Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res.69(10), 4116–4124 (2009).
  • Giampieri S, Manning C, Hooper S, Jones L, Hill CS, Sahai E. Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility. Nat. Cell Biol.11(11), 1287–1296 (2009).
  • Xue C, Plieth D, Venkov C, Xu C, Neilson EG. The gatekeeper effect of epithelial–mesenchymal transition regulates the frequency of breast cancer metastasis. Cancer Res.63(12), 3386–3394 (2003).
  • Trimboli AJ, Fukino K, de Bruin A et al. Direct evidence for epithelial-mesenchymal transitions in breast cancer. Cancer Res.68(3), 937–945 (2008).
  • Rhim AD, Mirek ET, Aiello NM et al. EMT and dissemination precede pancreatic tumor formation. Cell148(1–2), 349–361 (2012).
  • Tarin D, Thompson EW, Newgreen DF. The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res.65(14), 5996–6000; discussion 6000–6001 (2005).
  • Thompson EW, Newgreen DF, Tarin D. Carcinoma invasion and metastasis: a role for epithelial–mesenchymal transition? Cancer Res.65(14), 5991–5995; discussion 5995 (2005).
  • Yates C. Prostate tumor cell plasticity: a consequence of the microenvironment. Adv. Exp. Med. Biol.720, 81–90 (2011).
  • Gao D, Joshi N, Choi H et al. Myeloid progenitor cells in the premetastatic lung promote metastases by inducing mesenchymal to epithelial transition. Cancer Res.72(6), 1384–1394 (2012).
  • Gregory PA, Bert AG, Paterson EL et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol.10(5), 593–601 (2008).
  • Korpal M, Ell BJ, Buffa FM et al. Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nat. Med.17(9), 1101–1108 (2011).
  • Navin N, Kendall J, Troge J et al. Tumour evolution inferred by single-cell sequencing. Nature472(7341), 90–94 (2011).
  • Liu W, Laitinen S, Khan S et al. Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Nat. Med.15(5), 559–565 (2009).
  • Turajlic S, Furney SJ, Lambros MB et al. Whole genome sequencing of matched primary and metastatic acral melanomas. Genome Res.22(2), 196–207 (2012).
  • Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat. Rev. Cancer9(4), 239–252 (2009).
  • Toh B, Wang X, Keeble J et al. Mesenchymal transition and dissemination of cancer cells is driven by myeloid-derived suppressor cells infiltrating the primary tumor. PLoS Biol.9(9), e1001162 (2011).
  • Bonde AK, Tischler V, Kumar S, Soltermann A, Schwendener R. Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors. BMC Cancer12(1), 35 (2012).
  • Na YR, Seok SH, Kim DJ et al. Bone morphogenetic protein 7 induces mesenchymal-to-epithelial transition in melanoma cells, leading to inhibition of metastasis. Cancer Sci.100(11), 2218–2225 (2009).
  • Kobayashi A, Okuda H, Xing F et al. Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone. J. Exp. Med.208(13), 2641–2655 (2011).
  • Sakai H, Furihata M, Matsuda C et al. Augmented autocrine bone morphogenic protein (BMP) 7 signaling increases the metastatic potential of mouse breast cancer cells. Clin. Exp. Metastasis29(4), 327–338 (2012).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.